Cytosorbents Corp
CTSO- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001175151
In the last 90 days, Cytosorbents Corp insiders filed 4 open-market purchases and 0 sales; 50 institutions reported holding it in 13F filings for Q2 2026, worth $6.04M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Cytosorbents Corp changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 88 | 2 | 78 | −8 |
| Shares | 18.0M | 83.7K | 15.5M | −2.47M (−13.7%) |
| Value | $57.3M | $267.0K | $33.9M | −$23.1M (−40.5%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Cytosorbents Corp at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 524,661 | $1.15M | 0.00% |
| Ergoteles LLC | 202,700 | $444.0K | 0.01% |
| Susquehanna International Group, LLP | 51,262 | $112.0K | 0.00% |
| Texas Capital Bank Wealth Management Services Inc | 48,958 | $107.0K | 0.01% |
| Qube Research & Technologies Ltd | 35,293 | $77.0K | 0.00% |
| Country Club Bank | 15,225 | $34.0K | 0.00% |
| LMR Partners LLP | 14,709 | $32.0K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 14,304 | $31.0K | 0.00% |
| Balyasny Asset Management LLC | 11,761 | $26.0K | 0.00% |
| Key Client Fiduciary Advisors, LLC | 12,000 | $26.0K | 0.03% |
| Eudaimonia Partners, LLC | 11,000 | $24.0K | 0.00% |
| SEI Investments Co | 11,982 | $15.0K | 0.00% |
| Group One Trading, L.P. | 1,654 | $4.00K | 0.00% |
| Quadrant Capital Group LLC | 482 | $1.00K | 0.00% |
| Credit Suisse AG | 22 | $0 | 0.00% |
| Harvest Group Wealth Management, LLC | 37 | $0 | 0.00% |
Sold out (24)
Institutions that held Cytosorbents Corp at the end of Q1 2022 and filed for Q2 2022 without it.
Not filed for Q2 2022 yet (2)
Institutions that held Cytosorbents Corp at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 76,978 | $246.0K |
| Amalgamated Financial Corp. | 6,733 | $21.0K |